Search

Author/Creator Petta, S.

22. Fibroscan liver stiffness (LMS) and controlled attenuation parameter (CAP) in the evaluation of cardiovascular risk assessment in patients with NAFLD. Issue 1 (February 2018)

Authors:
Lombardi, R.; Petta, S.; Giannetti, A.; Boemi, R.; Pisano, G.; Bertelli, C.; Craxi, A.; Fargion, S.; Fracanzani, A.L.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. FNDC5 rs3480 A>G polymorphism disentangles steatosis from fibrosis severity in patients with nonalcoholic fatty liver disease. (10th February 2016)

Authors:
Petta, S.; Valenti, L.; Pipitone, R.M.; Dongiovanni, P.; Cammà, C.; Fracanzani, A.L.; Di Marco, V.; Milano, M.; Grimaudo, S.; Fargion, S.; Craxì, A.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Functional characterization of a novel genetic variant predisposing to hepatocellular carcinoma development in nonalcoholic fatty liver disease. Issue 1 (February 2018)

Authors:
Baselli, G.A.; Longo, M.; Meroni, M.; Pelusi, S.; Fracanzani, A.L.; Soardo, G.; Bugianesi, E.; Romagnoli, R.; Petta, S.; Miele, L.; De Francesco, R.; Fargion, S.; Dongiovanni, P.; Valenti, L.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. FXR rs35724 G>C variant modulates cholesterol levels, carotid atherosclerosis and liver damage in non-alcoholic fatty liver. (February 2019)

Authors:
Grimaudo, S.; Dongiovanni, P.; Pipitone, R.M.; Baselli, G.; Cammà, C.; Cabibi, D.; Di Marco, V.; Longo, M.; Pennisi, G.; Fargion, S.; Craxì, A.; Valenti, L.; Petta, S.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e26
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic Hepatitis C aged 75 years or older: A multicenter study. (March 2023)

Authors:
Pugliese, N.; Calvaruso, V.; Masarone, M.; D'Ambrosio, R.; Battistella, S.; Licata, A.; Persico, M.; Anolli, M.P.; Distefano, M.; Petta, S.; Russo, F.P.; Di Marco, V.; Aghemo, A.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S26
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

29. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗